Purchase Order HT942524P0008
Award Date
10/6/23
Potential Completion Date
5/5/24
Potential Value
$250K
Federal Agency
Defense Health Agency
Awardee
Emergingdx Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Mansfield, MA 02048, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
STTR Phase I
Primary Consortia Member
Not listed
Similar Awards
The Defense Health Agency (DHA) awarded a $249,837.63 Small Business Technology Transfer (STTR) Phase I contract to Emergingdx Inc., a small business subchapter S corporation based in Mansfield, Massachusetts. The contract is for the development of an automated detection platform for circulating and exosomal microRNAs, with potential applications in early disease detection and precision medicine. This contract is part of the DHA's research and development efforts in advanced diagnostic and...
This federal contract award is for a Small Business Innovation Research (SBIR) Phase I project from the Defense Health Agency (DHA) to Emergingdx Inc., a small business subchapter S corporation based in Mansfield, Massachusetts. The contract, valued at $249,993.61, supports the development of a "Rapid, Automated, Multiplexed Omics Platform" for medical research and diagnostic applications. As a total small business set-aside contract, this award demonstrates Emergingdx Inc.'s expertise...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Emergingdx Inc., a small business based in Mansfield, Massachusetts. The contract, valued at $1,299,988.98, supports the development of an automated detection platform for circulating and exosomal microRNAs. This research and development effort is focused on medical diagnostics and aligns with the DHA's mission to advance healthcare technologies. The contract was awarded on...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Emergingdx Inc., a small business subchapter S corporation based in Lowell, Massachusetts. The contract, valued at $1,299,985.23, supports the development of a "Multiplexed Diagnostic Platform for Invasive Fungal Infection." This contract builds on prior Phase I SBIR research and aims to advance a sophisticated diagnostic technology to address a critical need in the...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Department of the Army Materiel Command to Dxdiscovery Inc., a for-profit Subchapter S corporation, to conduct research and development efforts. The total award amount is $999,995.10, and the contract has a firm fixed price pricing type. The contract was awarded on December 20, 2017, with a completion date of February 13, 2020. The contract is set aside for total small business participation, and the potential...
Earlydiagnostics Inc., doing business as Earlydx, was awarded a $395,918 firm fixed price contract by the National Institutes of Health National Cancer Institute under the Small Business Innovation Research program. The contract has a total small business set aside designation. Earlydx will provide cloud-based development of a liquid-biopsy platform for the Cancer Research Data Commons, as requested in Topic 428 of the NIH/CDC SBIR solicitation seeking proposals for next generation...
<p>The U.S. Air Force Research Laboratory (AFRL) awarded a Small Business Innovation Research (SBIR) Phase II contract worth $1,249,994.00 to Dxlab Inc., a for-profit organization, for the development of a portable and rugged infection diagnostic platform that provides rapid, clinically actionable pathogen detection at deployed locations and military treatment facilities. The contract has a total small business set-aside designation and is set to be completed by December 8, 2025.</p>
<p>This federal contract award W81XWH15C0163 was issued by the U.S. Army Medical Command (MEDCOM) to Dxdiscovery Inc., a small business concern, under the Small Business Innovation Research (SBIR) program. The $149,714.90 firm-fixed-price contract is for Phase I of an SBIR project with a completion date of April 28, 2016. The contract is a definitive contract and has a total small business set-aside designation.</p>
This is a federal contract award (W911QY15C0058) made by the Joint PEO Chemical and Biological Defense, a Defense agency, to Dxdiscovery Inc., a small business, under the SBIR (Small Business Innovation Research) Program Phase II. The contract is a definitive, firm-fixed-price contract with a ceiling value of $999,822.46 and a period of performance ending on May 25, 2017. The contract is set aside for total small business participation. No additional details on the specific products or...
<p>This is a $2,000,000.00 fixed-price level-of-effort definitive contract awarded to Sense Diagnostics, Inc., a self-certified small disadvantaged business, by the Defense Health Agency for the SBIR Program Phase III action titled "PROPOSAL TP230368 DETECTION OF INTRACRANIAL". The contract has an ultimate completion date of June 19, 2027 and was awarded on September 20, 2024. This contract is not associated with a set-aside program.</p>